Evidence map›Paper›PMID 15048087›Full record

ArticleOncogene2004

Early B-cell factor-associated zinc-finger gene is a frequent target of retroviral integration in murine B-cell lymphomas.

Søren Warming, Takeshi Suzuki, Terry P Yamaguchi, Nancy A Jenkins, Neal G Copeland

Open access · bronzeAbstract read
PubMed Publisher
In one paragraph

Article in Oncogene, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Zfp423 controls proliferation and differentiation of neural precursors in cerebellar vermis formation.Proceedings of the National Academy of Sciences of the United States of America · 2006
    Article
  17. Zfp423 is required for normal cerebellar development.Molecular and cellular biology · 2006
    Article
  18. An expression screen reveals modulators of class II histone deacetylase phosphorylation.Proceedings of the National Academy of Sciences of the United States of America · 2005
    Article
  19. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Søren WarmingMouse Cancer Genetics Program, National Cancer Institute, Center for Cancer Research, West 7th Street at Fort Detrick, Frederick, MD 21702, USA.
Takeshi Suzuki
Terry P Yamaguchi
Nancy A Jenkins
Neal G Copeland
Center for Cancer Research · USCancer Genetics (United States) · US

Funding

The Role of Wnt Genes in Vertebrate Development and CancerZIABC010345 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI YAMAGUCHI, TERENCE · 2009 to 2025
$23.3M
The Role of Wnt Genes in Vertebrate Gastrointestinal DevZ01BC010345 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI YAMAGUCHI, TERENCE · 2000 to 2008
$1.2M
6 · The paper itself

Abstract

The early B-cell factor (EBF)-associated zinc-finger protein (EBFAZ) binds to and negatively regulates EBF, a basic helix-loop-helix transcription factor required for B-cell lineage commitment and development of the olfactory epithelium. It also binds to SMA- and MAD-related protein 1 (SMAD1) and SMAD4 in response to bone morphogenic protein 2 (BMP2) signaling. It is highly related to ecotropic viral integration site 3 (EVI3), a protein that, like EBFAZ, contains 30 Krüppel-like zinc-finger repeats. In previous studies, we showed that Evi3 is a frequent target of retroviral integration in AKXD27 B-cell lymphomas. Here, we show that EBFAZ is also a frequent target. Integrations at Ebfaz and Evi3 are mutually exclusive, suggesting that they function in the same tumor pathway. Lymphomas with integrations at Ebfaz or Evi3 express the pre-B-cell-specific marker immunoglobulin lambda chain 5, and contain immunoglobulin heavy-chain rearrangements, suggesting that they are blocked at an early B-cell stage. Unlike Evi3, which is expressed at low levels in normal B cells, or Ebfaz, which is not expressed in B cells, both genes are highly expressed following viral integration. Collectively, our results suggest that ectopic expression of Ebfaz can substitute for the upregulated expression of Evi3 in B-cell disease and highlight the importance of this gene family in hematopoietic cancer.

Indexed as

Transforming Growth Factor betaVirus IntegrationAmino Acid SequenceAnimalsBase SequenceBlotting, SouthernBone Morphogenetic Protein 2Bone Morphogenetic ProteinsDNA-Binding ProteinsDNA, ComplementaryExonsImmunoglobulin Heavy ChainsLymphomaLymphoma, B-CellMiceModels, GeneticBmp2 protein, mouseBmp2 protein, ratBone Morphogenetic Protein 2Bone Morphogenetic ProteinsDNA-Binding ProteinsDNA, ComplementaryEbfaz protein, mouseImmunoglobulin Heavy ChainsSmad1 ProteinSmad1 protein, mouseSmad4 ProteinSmad4 protein, mouseSmad4 protein, ratSmad ProteinsTrans-ActivatorsTranscription FactorsTransforming Growth Factor beta

Identifiers

PMID15048087
OpenAlexW2063612002

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.